GlassScriptPhysician profile
Scott J Matthews
NPI 1831527639
$5,404.74
in general payments reported to CMS, 2019-2025
23 companies · $889 in 2025
The $889 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $795 · 2020: $301 · 2021: $628 · 2022: $693 · 2023: $1,280 · 2024: $820 · 2025: $889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,688 · Entertainment: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,688.49 |
| Entertainment | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,501.50 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Abb Con-Cise Optical Group LLC | $1,089.41 | 2019-2024 | Spectacle Lenses, Contact Lens |
| Alcon Vision LLC | $702.38 | 2019-2025 | Total30, Rocklatan, Rhopressa |
| Johnson & Johnson Vision Care, INC. | $509.84 | 2019-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $344.14 | 2019-2024 | Cequa |
| Maculogix, INC. | $188.68 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $186.07 | 2022-2025 | Alden Scleral Zenlens, Infuse |
| Oyster Point Pharma, INC. | $124.68 | 2022-2023 | Tyrvaya |
| Abbvie INC. | $123.37 | 2022 | |
| Harrow Eye, LLC | $92.71 | 2024-2025 | Vevye |
| Allergan, INC. | $90.81 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $89.45 | 2019-2021 | |
| Thea Pharma INC. | $74.58 | 2023 | Iyuzeh |
| Rxsight INC | $57.69 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Kala Pharmaceuticals, INC. | $48.89 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Notal Vision, INC. | $35.00 | 2025 | Foresee Home |
| Mallinckrodt Hospital Products INC. | $27.95 | 2022 | |
| Aerie Pharmaceuticals, INC. | $26.12 | 2019 | |
| Dompe US, INC. | $24.54 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $19.33 | 2025 | Xdemvy |
| Eyevance Pharmaceuticals LLC | $19.10 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.07 | 2019 | |
| Shire North American Group INC | $13.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.